HEADER HYDROLASE 15-APR-99 1QA8 OBSLTE 23-JUN-00 1QA8 1GFW TITLE THE 2.8 ANGSTROM CRYSTAL STRUCTURE OF CASPASE-3 (APOPAIN OR TITLE 2 CPP32)IN COMPLEX WITH AN ISATIN SULFONAMIDE INHIBITOR. COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-3 (APOPAIN, P20); COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: ACTIVATED MATURE CASPASE-3 (P20) WITHOUT PRO- COMPND 5 DOMAIN OR LINKER (RESIDUES 29-175); COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CASPASE-3 (APOPAIN, P10); COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: ACTIVATED MATURE CASPASE-3 (P10) WITHOUT PRO- COMPND 11 DOMAIN OR LINKER (RESIDUES 181-277); COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 EXPRESSION_SYSTEM: E. COLI; SOURCE 5 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 EXPRESSION_SYSTEM: E. COLI; SOURCE 10 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) KEYWDS X-RAY, CASPASE INHIBITOR, CASPASE-3, APOPAIN, ISTIN KEYWDS 2 SULFONAMIDE EXPDTA X-RAY DIFFRACTION AUTHOR N.O.CONCHA,C.A.JANSON REVDAT 2 23-JUN-00 1QA8 1 OBSLTE REVDAT 1 17-APR-00 1QA8 0 JRNL AUTH D.LEE,G.CHAN,K.S.VAIDYA,T.A.FRANCIS,D.P.NADEAU, JRNL AUTH 2 M.W.LARK,M.GOWEN,K.KIKLY,J.D.WINKLER,C.-M.SUNG, JRNL AUTH 3 S.A.LONG,J.L.ADAMS,C.DEBOUCK,S.RICHARDSON,M.A.LEVY, JRNL AUTH 4 W.E.DEWOLF,JR.,P.M.KELLER,T.TOMASZEK,M.S.HEAD, JRNL AUTH 5 M.D.RYAN,R.C.HALTIWANGER,P.-H.LIANG,C.A.JANSON, JRNL AUTH 6 P.J.MCDEVITT,K.JOHANSON,N.O.CONCHA,W.CHAN, JRNL AUTH 7 S.S.ABDEL-MEGUID,M.E.NUTTALL JRNL TITL POTENT AND SELECTIVE NONPEPTIDE INHIBITORS OF JRNL TITL 2 CASPASES 3 AND 7 WHICH INHIBIT APOPTOSIS AND JRNL TITL 3 MAINTAIN CELL FUNCTIONALITY JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH T.FERNANDES-ALNEMRI,G.LITWACK,E.S.ALNEMRI REMARK 1 TITL CPP32, A NOVEL HUMAN APOPTOTIC PROTEIN WITH REMARK 1 TITL 2 HOMOLOGY TO CAENORHABDITIS ELEGANS CELL DEATH REMARK 1 TITL 3 PROTEIN CED-3 AND MAMMALIAN REMARK 1 TITL 4 INTERLEUKIN-1-B-CONVERTING ENZYME REMARK 1 REF J.BIOL.CHEM. V. 269 30761 1994 REMARK 1 REFN ASTM JBCHA3 US ISSN 0021-9258 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851, CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : SEE ENGH & HUBER (1991) ACTA CRYST A 47, REMARK 3 392-400. REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1413969.370 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.3 REMARK 3 NUMBER OF REFLECTIONS : 6386 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.800 REMARK 3 FREE R VALUE TEST SET COUNT : 687 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.011 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.90 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 824 REMARK 3 BIN R VALUE (WORKING SET) : 0.2800 REMARK 3 BIN FREE R VALUE : 0.3450 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 84 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.038 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1923 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 45 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 47.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM SIGMAA (A) : 0.42 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.44 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 BOND ANGLES (DEGREES) : 1.70 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.89 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.560 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.500 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.290 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.250 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 33.28 REMARK 3 BSOL : 0.36 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : 277.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: DATA COLLECTION PROCEEDED IN THE REMARK 3 PRESENCE OF "ICE-RINGS" REMARK 4 REMARK 4 1QA8 COMPLIES WITH FORMAT V. 3.0, 1-DEC-2006 REMARK 4 REMARK 4 THIS IS THE REMEDIATED VERSION OF THIS PDB ENTRY. REMARK 4 REMEDIATED DATA FILE REVISION 3.101 (2007-05-29) REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB. REMARK 100 THE RCSB ID CODE IS RCSB009069. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JAN-1998 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.90 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X12B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.100 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : QUANTUM-4 (ADSC) REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR, DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6775 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.17400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 4.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.26700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 4 UL HANGING DROPS WERE PREPARED BY REMARK 280 MIXING EQUAL VOLUMES OF PROTEIN (10 MG/ML IN 20 MM HEPES, PH REMARK 280 7.0) AND RESERVOIR SOLUTION. THE DROPS EQUILIBRATED AGAINST REMARK 280 500 UL OF 15-18% PEG6000, 0.1M SODIUM CITRATE, PH 5.9, 20 MM L REMARK 280 -CYSTEINE, AND 5% GLYCEROL., VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 1/2+X,1/2+Y,1/2+Z REMARK 290 6555 1/2-X,1/2-Y,1/2+Z REMARK 290 7555 1/2-X,1/2+Y,1/2-Z REMARK 290 8555 1/2+X,1/2-Y,1/2-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 33.60000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 41.65000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 48.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 33.60000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 41.65000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 48.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 33.60000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 41.65000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 48.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 33.60000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 41.65000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 48.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 174 REMARK 465 ASP A 175 REMARK 465 ASP B 181 REMARK 465 MET B 182 REMARK 465 ALA B 183 REMARK 465 CYS B 184 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI REMARK 500 O ARG B 241 OG1 THR B 245 2.08 REMARK 500 ND2 ASN A 51 OG1 THR A 67 2.11 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY A 129 N - CA - C ANGL. DEV. =-15.3 DEGREES REMARK 525 REMARK 525 SOLVENT REMARK 525 THE FOLLOWING SOLVENT MOLECULES LIE FARTHER THAN EXPECTED REMARK 525 FROM THE PROTEIN OR NUCLEIC ACID MOLECULE AND MAY BE REMARK 525 ASSOCIATED WITH A SYMMETRY RELATED MOLECULE (M=MODEL REMARK 525 NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH 15 DISTANCE = 6.98 ANGSTROMS REMARK 525 HOH 33 DISTANCE = 6.02 ANGSTROMS REMARK 525 HOH 36 DISTANCE = 5.52 ANGSTROMS REMARK 525 HOH 37 DISTANCE = 9.50 ANGSTROMS REMARK 525 HOH 38 DISTANCE = 5.64 ANGSTROMS REMARK 525 HOH 39 DISTANCE = 5.47 ANGSTROMS REMARK 525 HOH 46 DISTANCE = 6.06 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1PAU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE REMARK 900 TETRAPEPTIDE ALDEHYDE INHIBITOR AC-DEVD-CHO REMARK 900 RELATED ID: 1CP3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE REMARK 900 TETRAPEPTIDE INHIBITOR AC- DVAD-FMC DBREF 1QA8 A 29 175 UNP P42574 ICE3_HUMAN 29 175 DBREF 1QA8 B 181 277 UNP P42574 ICE3_HUMAN 181 277 SEQRES 1 A 147 SER GLY ILE SER LEU ASP ASN SER TYR LYS MET ASP TYR SEQRES 2 A 147 PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN LYS ASN SEQRES 3 A 147 PHE HIS LYS SER THR GLY MET THR SER ARG SER GLY THR SEQRES 4 A 147 ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE ARG ASN SEQRES 5 A 147 LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU THR ARG SEQRES 6 A 147 GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER LYS GLU SEQRES 7 A 147 ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL LEU LEU SEQRES 8 A 147 SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR ASN GLY SEQRES 9 A 147 PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE ARG GLY SEQRES 10 A 147 ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS LEU PHE SEQRES 11 A 147 ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP CYS GLY SEQRES 12 A 147 ILE GLU THR ASP SEQRES 1 B 97 ASP MET ALA CYS HIS LYS ILE PRO VAL ASP ALA ASP PHE SEQRES 2 B 97 LEU TYR ALA TYR SER THR ALA PRO GLY TYR TYR SER TRP SEQRES 3 B 97 ARG ASN SER LYS ASP GLY SER TRP PHE ILE GLN SER LEU SEQRES 4 B 97 CYS ALA MET LEU LYS GLN TYR ALA ASP LYS LEU GLU PHE SEQRES 5 B 97 MET HIS ILE LEU THR ARG VAL ASN ARG LYS VAL ALA THR SEQRES 6 B 97 GLU PHE GLU SER PHE SER PHE ASP ALA THR PHE HIS ALA SEQRES 7 B 97 LYS LYS GLN ILE PRO CYS ILE VAL SER MET LEU THR LYS SEQRES 8 B 97 GLU LEU TYR PHE TYR HIS HET MSI 301 28 HETNAM MSI 1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)- HETNAM 2 MSI 1H-INDOLE-2,3-DIONE FORMUL 3 MSI C20 H20 N2 O5 S FORMUL 4 HOH *45(H2 O) HELIX 1 1 HIS A 56 GLY A 60 5 5 HELIX 2 2 GLY A 66 LEU A 81 1 16 HELIX 3 3 THR A 92 GLU A 106 1 15 HELIX 4 4 LEU A 136 ASN A 141 1 6 HELIX 5 5 PHE A 142 ARG A 144 5 3 HELIX 6 6 CYS A 148 THR A 152 5 5 HELIX 7 7 TRP B 214 ALA B 227 1 14 HELIX 8 8 GLU B 231 PHE B 247 1 17 HELIX 9 9 ASP B 253 HIS B 257 5 5 SHEET 1 A 6 GLU A 84 ASN A 89 0 SHEET 2 A 6 LEU A 46 ASN A 51 1 O CYS A 47 N ARG A 86 SHEET 3 A 6 PHE A 114 LEU A 119 1 O VAL A 115 N ILE A 48 SHEET 4 A 6 LYS A 156 GLN A 161 1 N LEU A 157 O PHE A 114 SHEET 5 A 6 PHE B 193 TYR B 197 1 O LEU B 194 N PHE A 158 SHEET 6 A 6 CYS B 264 SER B 267 -1 N CYS B 264 O TYR B 197 SHEET 1 B 3 GLY A 122 GLU A 123 0 SHEET 2 B 3 ILE A 126 PHE A 128 -1 N ILE A 126 O GLU A 123 SHEET 3 B 3 PRO A 133 ASP A 135 -1 O VAL A 134 N ILE A 127 SHEET 1 C 2 GLY A 165 GLU A 167 0 SHEET 2 C 2 GLY B 202 TYR B 203 1 O GLY B 202 N GLU A 167 SHEET 1 D 2 ARG B 207 ASN B 208 0 SHEET 2 D 2 GLY B 212 SER B 213 -1 O GLY B 212 N ASN B 208 CRYST1 67.200 83.300 96.000 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014881 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012005 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010417 0.00000